Deep Brain Stimulation

Deep Brain Stimulation is a neurosurgical procedure that uses a neurostimulator to stimulate specific regions of the brain for treatment of movement disorders. Here is the latest research.

July 28, 2020

Central sensitization of nociceptive pathways demonstrated by robot-controlled pinprick-evoked brain potentials

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
E N van den BroekeA Mouraux
August 1, 2020
Open Access

Brain-Machine Neurofeedback: Robotics or Electrical Stimulation?

Frontiers in Bioengineering and Biotechnology
Robert GuggenbergerAlireza Gharabaghi
July 28, 2020

Education moderates the effect of tDCS on episodic memory performance in cognitively impaired patients

Brain Stimulation
Christine KrebsJessica Peter
July 30, 2020

Subthalamic nucleus deep brain stimulation suppresses neuroinflammation by Fractalkine pathway in Parkinson's disease rat model

Brain, Behavior, and Immunity
Yingchuan ChenJianguo Zhang
July 31, 2020

The deep and slow breathing characterizing rest favors brain respiratory-drive

BioRxiv : the Preprint Server for Biology
B. GirinNathalie Buonviso
August 1, 2020
Open Access

Body Concept and Quality of Life in Patients with Idiopathic Dystonia

Brain Sciences
Lejla ParackaJoachim K Krauss
July 28, 2020

Hybrid optogenetic and electrical stimulation for greater spatial resolution and temporal fidelity of cochlear activation

BioRxiv : the Preprint Server for Biology
A. C. ThompsonRachael T Richardson
August 4, 2020

Interactive computation and visualization of deep brain stimulation effects using Duality

Computer Methods in Biomechanics and Biomedical Engineering. Imaging & Visualization
J VorwerkC R Butson
July 28, 2020

Histaminergic control of corticostriatal synaptic plasticity during early postnatal development

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Sungwon HanTommas Ellender
August 1, 2020
Comment / Editorial

Editorial. Achieving optimal outcomes with deep brain stimulation for posttraumatic stress disorder

Journal of Neurosurgery
Michael D StaudtJulie G Pilitsis
August 1, 2020

Neurostimulation for treatment-resistant posttraumatic stress disorder: an update on neurocircuitry and therapeutic targets

Journal of Neurosurgery
M Benjamin LarkinSameer A Sheth
July 28, 2020
Open Access

Bilateral double beta peaks in a PD patient with STN electrodes

Acta neurochirurgica
Thomas KoeglspergerKai Bötzel
August 1, 2020

Quality of life outcomes after globus pallidus internus deep brain stimulation in idiopathic or inherited isolated dystonia: a meta-analysis

Journal of Neurology, Neurosurgery, and Psychiatry
Takashi TsuboiAdolfo Ramirez-Zamora
July 31, 2020

Truncated aptamers as selective receptors in a gluten sensor supporting direct measurement in a deep eutectic solvent

Biosensors & Bioelectronics
Rossella SvigeljMaría Jesús Lobo-Castañón
July 28, 2020

Risk Factors for Wire Fracture or Tethering in Deep Brain Stimulation: A 15-Year Experience

Operative Neurosurgery
Charles E MackelRon L Alterman

Sign up to follow this feed and discover related papers.

Related Feeds


Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.


ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.


This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Alpha-Synuclein Structure and Function

α-Synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. Here is the latest research on α-Synuclein structure and function.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

© 2020 Meta ULC. All rights reserved